Treatment of Psychogenic Polydipsia
The primary treatment of psychogenic polydipsia requires optimizing antipsychotic therapy for the underlying psychotic disorder, combined with behavioral interventions including water restriction and self-monitoring, with adjunctive pharmacological agents (acetazolamide, vaptans, or candesartan) for refractory cases causing hyponatremia. 1, 2, 3
Immediate Management of Acute Hyponatremia
- Stabilize severe hyponatremia first if sodium is critically low (<120 mEq/L) or if seizures occur, using careful sodium correction to avoid osmotic demyelination syndrome 1, 3
- Admit patients presenting with hyponatremia-induced seizures or altered mental status for close monitoring 1, 4
- Correct sodium slowly, typically achieving normalization over 2-3 weeks in severe cases 3
Optimize Antipsychotic Treatment
Address the underlying psychotic disorder as the foundation of treatment, since psychogenic polydipsia occurs predominantly in patients with schizophrenia and schizoaffective disorder 5, 6
- Ensure therapeutic dosing of current antipsychotic for at least 4 weeks before switching 5
- If polydipsia persists with inadequate psychosis control, switch to an alternative antipsychotic with different pharmacodynamic profile using gradual cross-titration 5
- Consider clozapine for treatment-resistant cases, as it may address both refractory psychosis and compulsive water drinking 5
- Restart or optimize antipsychotics in patients who stopped medications, as acute psychotic episodes can exacerbate arginine vasopressin dysregulation and worsen polydipsia 6
Behavioral and Environmental Interventions
Implement behavioral therapy as a cornerstone intervention, which has demonstrated effectiveness in reducing water intake from extreme levels (15 liters/day) to normal range (3 liters/day) 1
- Institute water restriction protocols in inpatient settings 7, 3
- Teach self-monitoring techniques for tracking daily fluid intake 1
- Provide psychoeducation to patients and family members about the risks of excessive water consumption 4
- Use diurnal weight measurements to monitor water balance objectively 2
- Address environmental triggers and modify compulsive behaviors through structured behavioral modification therapy 1, 4
Pharmacological Adjuncts for Refractory Cases
When behavioral interventions and optimized antipsychotics prove insufficient:
First-line adjunctive agent:
- Acetazolamide shows marked improvement in reducing compulsion to drink and correcting hyponatremia, is well-tolerated, and improves quality of life 2, 3
Alternative agents:
- Vaptans (vasopressin receptor antagonists) can treat arginine vasopressin dysregulation during acute psychotic episodes 6
- Candesartan (angiotensin receptor blocker) may be used as part of combination therapy for persistent hyponatremia 3
Combination regimen for severe cases:
A successful protocol included acetazolamide, candesartan, optimized antipsychotic (olanzapine), and sodium chloride supplementation, achieving sodium normalization by day 21 3
Electroconvulsive Therapy for Treatment-Resistant Cases
Consider ECT for chronic, refractory psychogenic polydipsia with persistent hyponatremia when standard treatments fail 7
- An acute course of 8 bilateral ECT sessions normalized serum sodium in a patient with chronic schizophrenia and moderate hyponatremia refractory to all other interventions 7
- Sodium remained stable during and after ECT despite months of prior high variability 7
- This option is particularly relevant for patients requiring chronic institutionalization with poor quality of life due to uncontrolled polydipsia 7
Monitoring Strategy
- Perform weekly comprehensive metabolic panels to track sodium levels during treatment 2
- Use daily weight measurements to assess water balance objectively 2
- Routinely screen all schizophrenia patients for polydipsia in clinic visits, as this complication is common and can lead to fatal consequences if unaddressed 4
Critical Pitfalls to Avoid
- Never overlook psychogenic polydipsia in young, systemically healthy psychiatric patients presenting with polyuria/polydipsia, as delayed recognition increases morbidity and mortality risk 1, 4
- Do not correct severe hyponatremia too rapidly—risk of osmotic demyelination syndrome is significant 3
- Avoid attributing hyponatremia solely to SIADH without considering the polydipsia component, especially when urine osmolality is normal 6
- Do not discharge patients with active severe hyponatremia without achieving stabilization and implementing outpatient monitoring plan 1